Table 1.

Group categories for trends in CRC incidence and mortality in 2000–2019 among 60 countries.

Group	Incidence	Mortality	Countries (AAPC of incidence, AAPC of mortality)
Group A	Increasing	Increasing	China (3.82, 1.18), Ecuador (3.02, 2.22), Costa Rica (2.64, 1.82), Romania (2.47, 1.41), Republic of Moldova (2.36,1.55), Mexico (2.28, 1.68), Chile (2.00, 0.77), Mauritius (1.79, 1.28), Grenada (1.77, 1.31), Panama (1.70, 1.00), Cuba (1.70, 0.89), Guatemala (1.64, 1.06), Serbia (1.61, 0.41), Croatia (1.54, 0.60), Barbados (1.52, 0.94), Fiji (1.38, 1.14), Philippines (1.28, 0.96), Saint Lucia (1.13, 0.47)
Group B	Increasing	Stable	Kuwait (1.62, 0.57), Antigua and Barbuda (1.42, 0.76), Colombia (1.08, −0.09), Spain (0.99, −0.07), Brazil (0.75, −0.01), Argentina (0.66, 0.06)
Group C	Increasing	Decreasing	Estonia (1.40, −0.43), Republic of Korea (1.39, −0.54), Puerto Rico (0.87, −0.34), Slovakia (0.82, −0.36), Latvia (0.65, −0.34), Poland (0.65, −0.23), Netherlands (0.54, −0.46), Finland (0.48, −0.56), Malta (0.24, −0.78)
Group D	Stable	Stable	Trinidad and Tobago (0.55, −0.14), Lithuania (0.31, −0.26), Guyana (0.28, 0.05)
Group E	Stable	Decreasing	Slovenia (−0.12, −1.42), Denmark (0.06, −1.33), United Kingdom (0.10, −0.97), Kyrgyzstan (−0.36, −0.84), Hungary (0.08, −0.77), Japan (0.09, −0.75), Greece (0.09, −0.57), Canada (0.05, −0.56), Uruguay (0.05, −0.48)
Group F	Decreasing	Decreasing	Austria (−2.19, −2.74), Luxembourg (−1.60. −2.33), Germany (−1.53, −2.51), Israel (−1.25, −2.22), Switzerland (−1.13, −1.45), Singapore (−0.85, −2.26), Australia (−0.78, −1.58), Iceland (−0.72, −1.22), United States of America (−0.69, −1.05), Belgium (−0.46, −1.25), France (−0.44, −1.33), New Zealand (−0.42, −1.22), Italy (−0.42, −1.11), Sweden (−0.38, −0.84), Norway (−0.24, −1.10)

“Increasing” or “decreasing” were used when the AAPC was statistically significant (P < 0.05); otherwise, the term “stable” was used. AAPC: Average annual percent change; CRC: Colorectal cancer.